Roche gets second European approval for Alzheimer’s test
Swiss drugmaker Roche has received the CE mark – a European regulatory clearance allowing sale in the region…
Roche wins CE mark for Elecsys Alzheimer’s blood test
Roche (OTCQX:RHHBY) received a CE mark for its Elecsys pTau217 blood test, developed…
Roche enters into a definitive merger agreement to acquire PathAI to transform AI-driven diagnostics
PathAI’s best-in-class Image Management System (IMS) with advanced AI analysis and workflow capabilities will complement Roche’s digital pathology…
Roche to acquire Pathai for up to $1.05B
Roche Holding AG has agreed to acquire Pathai Inc. for up to $1.05 billion in a bid to…
Swiss startup Moonlight AI raises €2.8 million to turn routine blood and cytology imaging into genomic insights
Moonlight AI, a Swiss startup building image analysis software for clinical-grade diagnostics, has closed a €2.8 million ($3.3…
Roche Holding AG: Defensive Giant At A Crossroads As Investors Weigh Pipeline Against Pricing Pressu
Roche’s stock has quietly slipped over the past days, even as analysts highlight a resilient pipeline and robust…
Foundation Medicine buying Saga Dx and its MRD test for $595M
Nearly a year after the first U.S. commercial launch of the multicancer molecular residual disease (MRD) detection platform…
Saudi Arabia In-Vitro Diagnostics (IVD) Market Report 2025-2034 Featuring Roche, Danaher, Abbott Laboratories, Thermo Fischer Scientific, Bio-Rad Laboratories, Sysmex, BD & Co, and Biomerieux
Company Logo The Saudi Arabia in vitro diagnostics (IVD) market is set for steady growth, driven by the…
HNL Lab Medicine Celebrates Preferred Partnership With Roche Diagnostics
HNL Lab Medicine Celebrates Preferred Partnership With Roche Diagnostics HNL Lab Medicine and Roche Diagnostics mark the formalization…
Coronavirus testing is starting to get better — but it has a long way to go
Friday morning a ray of light cracked through the ominous cloud of the pandemic caused by the novel…
Roche Q1 sales rise 6% CER, outlook confirmed
Roche (OTCQX: RHHBY) reported Group sales of CHF 14.7bn in Q1 2026: +6%…
Defensive Giant At A Crossroads As Investors Weigh Pipeline Against Pricing Pressu
Roche’s stock has quietly slipped over the past days, even as analysts highlight a resilient pipeline and robust…